Product




An Innovative Approach to Stop Active Bone Bleeding

Throughout the history of surgery, there has been a need for a solution to safely stop active bone bleeding. At last, an innovative, synthetic, resorbable hemostatic bone putty, HEMASORB, moves bone bleeding management into a new era. HEMASORB is today’s solution for bone hemostasis.

Easy to Use

  • Stops bone bleeding upon application 1,2
  • Remains in place
  • Offers controlled, precise application
  • Conforms to the site of care
  • Does not require warming or kneading
  • Ready to use out of package

Resorbable

  • Substantially resorbs within 30 days 1,3
  • Implantation sites assessed at 6 and 8 weeks 3
  • Does not swell

Synthetic (Tissue-Free)

  • Is free from tissue-derived components
  • Meets the ISO10993 standards for biocompatibility
HEMASORB provides an advanced, practical solution to actively and reliably stop bone bleeding. HEMASORB is easy to use, synthetic (tissue-free), and substantially resorbs within 30 days. 1,2

1 When used according to the Instructions For Use.
2 Based on animal and human data on file, ORTHOCON, Inc.*
3 Based on animal data on file, ORTHOCON, Inc.*
* Results from animal studies may not be indicative of clinical results.






ORTHOCON® estimates that over 3.5 million patients undergoing surgeries in the United States and Europe each year could benefit from the intraoperative use of HEMASORB.


New Company Abyrx, Inc. Acquires Substantially All of the Assets of Orthocon and DRG
April 24, 2013 - Click to Download

ORTHOCON® Announces Uninterrupted Availability of HEMASORB Resorbable Hemostatic Bone Putty
August 23, 2012 - Click to Download